Total U.S. permanent implant procedures declined 7% year over year, while U.S. trial procedures decreased 14.2% year over year. During the fourth quarter of 2024, Nevro made significant ...

minimized bone removal and increased fusion potential compared to a posterolateral cylindrical-threaded single-implant system. Expansion of SCS Systems Into the PDN Market: Nevro’s focus on ...

According to GMED administration, the deal allows them to expand into new markets for future growth while gaining access to Nevro’s world-class, differentiated technologies that can provide ...

A contraceptive implant is a thin and flexible rod that sits under the skin and releases contraceptive drugs into the body for years. While it’s one of the most effective forms of contraceptives ...

U.S. permanent implant procedures decreased by 7.0% compared ... an increase of $15.5 million from September 30, 2024. Nevro's full-year 2024 worldwide revenue was $408.5 million, a decrease ...

NEVRO ($NVRO) is expected to release its quarterly earnings data on Tuesday, March 4th after market close, per Finnhub. Analysts are expecting revenue of $104,594,880 ...